(Q35183740)

7 August 2017

1 reference

title

Treatment of Acinetobacter spp infections (English)

1 reference

7 August 2017

Anna S Levin

1

1 reference

PubMed ID

12877637

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Expert Opinion on Pharmacotherapy

7 August 2017

1 reference

7 August 2017

4

1 reference

7 August 2017

8

1 reference

7 August 2017

1289-1296

1 reference

Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study

7 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Infections in a burn intensive care unit: experience of seven years

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

An outbreak of Acinetobacter baumannii: the importance of cross-transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Aerators as a reservoir of Acinetobacter junii: an outbreak of bacteraemia in paediatric oncology patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Eradication of multi-drug resistant Acinetobacter from an intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Investigation of an outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care burns unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

A nosocomial outbreak of multiresistant Acinetobacter baumannii originating from an intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgical patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Environmental contamination during a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Surveillance of antibiotic resistance in European ICUs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Comparative studies of the Acinetobacter genus and the species identification method based on the recA sequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Characteristics of clinical Acinetobacter spp. strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Bacterial resistance to antimicrobial agents in Latin America. The giant is awakening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

A reassessment of the in-vitro activity of colistin sulphomethate sodium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Antibiotic synergy and antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Bactericidal in-vitro activity of beta-lactams and beta-lactamase inhibitors, alone or associated, against clinical strains of Acinetobacter baumannii: effect of combination with aminoglycosides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

In vitro investigation of the susceptibility of Acinetobacter baumannii strains isolated from clinical specimens to ampicillin/sulbactam alone and in combination with amikacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Ticarcillin plus clavulanic acid versus moxalactam therapy of osteomyelitis, septic arthritis, and skin and soft tissue infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Nontraditional dosing of ampicillin-sulbactam for multidrug-resistant Acinetobacter baumannii meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1289

10.1517/14656566.4.8.1289

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12877637